The Efficacy of Low-level Laser Therapy in Relieving Vaginal Dryness and Lower Urinary Tract Symptoms
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Vaginal Atrophy
- Sponsor
- National Taiwan University Hospital
- Enrollment
- 41
- Locations
- 1
- Primary Endpoint
- Vaginal health
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) are common for women. Low-level laser therapy (LLLT) was applied for wound healing, but there was no study regarding treatment effect of GSM and SUI. This retrospective study aims to assess the efficacy of LLLT in alleviating GSM and SUI.
Detailed Description
Between September 2022 and August 2023, all women who received LLLT for GSM and SUI at the gynecologic outpatient clinic of a hospital were retrospectively reviewed. The treatment was once a week for eight weeks. Vaginal health index (VHI) and questionnaires before and after treatment for evaluation of lower urinary tract symptoms (LUTS) and quality of life are the outcome assessment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •women with GSM and SUI
- •Received LLLT at the gynecologic outpatient clinic
Exclusion Criteria
- •More or equal to stage 2 pelvic organ prolapse defined by pelvic organ prolapse-quantification system
- •Ongoing urinary tract infection or vaginitis with the pathogen in the previous 2 weeks
- •Bladder calculus
- •Neurogenic bladder due to radical hysterectomy or injury of the central nervous system
- •A preexisting malignant pelvic tumor.
Outcomes
Primary Outcomes
Vaginal health
Time Frame: 8 weeks
Vaginal health index, each of these 5 items is evaluated by means of a scale from 1 (none) to 5 (excellent) and then the average of the scores is calculated. A value of ≤15 (= cut-off) is generally considered for the diagnosis of low vaginal health.
Secondary Outcomes
- Urinary incontinence(8 weeks)